Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

9.78
+0.57006.19%
Post-market: 9.780.00000.00%19:30 EDT
Volume:1.76M
Turnover:17.03M
Market Cap:1.65B
PE:-5.76
High:9.86
Open:9.31
Low:9.31
Close:9.21
52wk High:11.66
52wk Low:4.35
Shares:168.65M
Float Shares:130.00M
Volume Ratio:1.24
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6972
EPS(LYR):-3.1619
ROE:-26.08%
ROA:-14.51%
PB:1.68
PE(LYR):-3.09

Loading ...

May 06, 2021

Major Issues Report

8-K - Current report
Apr 14, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Major Issues Report

8-K - Current report
Mar 30, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 19, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Major Issues Report

8-K - Current report
Dec 29, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]